Global MRI-Guided Neurosurgical Ablation Market

Global MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers) - Industry Forecast 2024-2031


Report ID: SQMIG35H2181 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 76

Global MRI-Guided Neurosurgical Ablation Market Insights

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 566.92 million in 2021 and is poised to grow from USD 608.31 million in 2022 to USD 1068.86 million by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

The growth of the market is due to the rising incidence of nervous system-related diseases and brain tumors, as well as the growing use of less invasive neurosurgery techniques. Moreover, the market is driven by the increasing use of minimally invasive neurosurgery treatments.

Because minimally invasive surgeries can advance recovery, patients are choosing them more. Neurosurgeons use a variety of specialized instruments to reduce tissue injury during these procedures. Compared to typical surgical approaches, this strategy lowers surgical risks and requires fewer incisions and instruments.

Furthermore, In February 2022, Researchers at UCL created a revolutionary cancer treatment that heats and destroys tumors by using an MRI scanner to direct a magnetic seed across the brain. This treatment eradicates the tumor accurately without damaging healthy tissues, potentially avoiding usual harmful effects.

In addition to reducing the number of notches needed, this procedure has the added benefit of cosmetically beating wounds. Applications for minimally aggressive techniques include the treatment of benign and malignant brain tumors.

These techniques are less intrusive, which allows surgeons to spend more time doing other surgeries and allows patients to recover more speedily. Because minimally invasive procedures have many profits over traditional treatment options, doctors are increasingly endorsing them to patients during neurosurgical surgeries.

Developments in high-resolution, real-time magnetic resonance imaging (MRI) have enhanced the accuracy and safety of neurosurgery procedures. These improvements have allowed surgeons to visualize the brain in real-time, display the ablation process, and change course throughout the procedure as necessary.

This tactic has reduced the risk of destructive healthy brain tissue while also improving patient consequences. For instance, in December 2022, physicians at UT Southwestern introduced an enhanced aiming technique known as four-tract tractography.

This innovation aims to adapt MRI-guided, high-intensity focused ultrasound (HIFU) treatments, which are utilized at UTSW for patients with medication-resistant tremors in essential tremor and tremor-dominant Parkinson's disease.

One of the high influences contributing to the growth of the market is the rising number of patients with brain tumors. According to the American Cancer Society, there will be almost 24,810 new instances of brain and other nervous system cancer in 2023, and there will be 18,990 estimated deaths from these cases.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 566.92 million in 2021 and is poised to grow from USD 608.31 million in 2022 to USD 1068.86 million by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

The market competitive landscape for neurosurgical ablation guided by magnetic resonance imaging (MRI) offers information fragmented down by intranet. In-depth information is provided about the product launch, product width and breadth, application dominance, new market initiatives, company strengths, weaknesses, production facilities and sites, production capacities, R&D spending, finances, and Revenue. 'Medtronic', 'InSightec Ltd.', 'Elekta AB', 'Monteris Medical', 'Profound Medical', 'Boston Scientific Corporation', 'MR Solutions', 'MRI Interventions, Inc.', 'Varian Medical Systems', 'AngioDynamics', 'Abbott Laboratories', 'Hitachi Medical Systems', 'Siemens Healthineers', 'IMRIS, Deerfield Imaging', 'Accuray Incorporated', 'Perseon Corporation', 'Elekta AB', 'Isacord', 'Monteris Medical', 'Focal Therapeutics', 'Shamrad Electronics'

The demand is mostly driven by the increased prevalence of neurological conditions. Numerous diseases impact the nervous system, which are characterized as neurological disorders. Some of these disorders have the potential to be fatal or extremely disabling. Innovative therapeutic methods like MRI-guided neurosurgical ablation are becoming more popular.

Patient-centric care is an essential trend in the MRI-guided neurosurgical ablation market, emphasizing a personalized approach to treatment. This patient-centered model places the individual at the heart of decision-making, since their exclusive needs and preferences. In the context of MRI-guided ablation, patient-centric care interprets into adapting procedures to the specific condition and characteristics of each patient. This approach not only arranges minimally invasive, exact treatments but also encourages collective decision-making, safeguarding that patients are active participants in their healthcare journey. As a result, patient-centric care improves the overall experience, encourages positive outcomes, and aligns with the broader shift towards more adapted and responsive healthcare services in neurosurgery.

North America held a 34.6% market share. This is illuminated by the region's well-established healthcare facilities, the rising prevalence of brain tumors and malignancies, and the convenience of highly qualified neurosurgeons. The market for North America is primarily driven by the rising incidence of detailed disorders including brain tumors, most of which are malignant, and neurodegenerative diseases. Additionally, the market expansion in the area is being supported by the incidence of significant important players. Thus, the primary factors driving the market are the increasing number of minimally invasive neurosurgery procedures and the rising incidence of neurological diseases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global MRI-Guided Neurosurgical Ablation Market

Product ID: SQMIG35H2181

$5,300
BUY NOW GET FREE SAMPLE